[1] 向元兵,胡耀. 糖尿病肾病患者血清TRPM7、Sirtuin-1与钙磷代谢、颈动脉钙化的相关性[J]. 中国现代医学杂志,2023,33(12):86-91. DOI: 10.3969/j.issn.1005-8982. 2023.12.013.
[2] 刘春芳,席悦,李冰. 糖尿病肾病合并心血管疾病危险因素研究的进展[J]. 心血管康复医学杂志,2022,31(4):500-503. DOI: 10.3969/j.issn.1008-0074.2022.04.24.
[3] 路曼,周小春,刘芳香,等. 糖尿病肾病合并心血管疾病的影响因素分析及风险预测模型构建[J]. 中国医药,2023,18(12):1812-1816. DOI: 10.3760/j.issn.1673-4777.2023. 12.012.
[4] 张驰,谢晓慧,郑芳芳,等.血清Fetuin-A、NGAL对糖尿病肾病的早期诊断价值[J]. 中国现代医学杂志,2023,33(1):1-6. DOI: 10.3969/j.issn.1005-8982.2023.01.001.
[5] 赵丽珍,李卫民,姜瑞霞.系统免疫炎症指数对社区老年2型糖尿病患者并发糖尿病肾病的临床诊断价值研究[J]. 中国全科医学,2023,26(18):2227-2231. DOI: 10.12114/j.issn.1007-9572.2022.0873.
[6] 姚立军,陈立娟,耿欣,等. 休克指数和纤维蛋白原对老年严重创伤患者并发创伤性凝血病的发生及预后价值[J]. 中国老年学杂志,2023,43(7):1619-1623. DOI: 10.3969/j.issn.1005-9202.2023.07.023.
[7] 刘庆阳,殷剑,王秋波. 类风湿关节炎患者外周血白细胞CCL5表达水平与TNF-α抑制剂治疗效果的相关性研究[J]. 标记免疫分析与临床,2023,30(1):67-71. DOI: 10.11748/bjmy.issn.1006-1703.2023.01.013.
[8] 胡茂清. 糖尿病的新诊断标准与分型[J]. 华中医学杂志,1999, (2):90-91,78.
[9] 王晓强,王晓雷,于佳佳,等. 联合口服SGLT-2抑制剂、中药"肾四味"对Ⅲ~Ⅳ期糖尿病肾病患者蛋白尿水平的影响[J]. 山东医药,2023,63(8):68-70. DOI:10.3969/j.issn.1002-266X.2023.08.017.
[10] 陈馨韵,尹清华,付平. 脂代谢紊乱在糖尿病肾病发病机制中的研究进展[J]. 中华肾脏病杂志,2021,37(9):771-778. DOI: 10.3760/cma.j.cn441217-20200804-00114.
[11] 陈璟,李文亚,邵翔,等. 血清皮质醇、促肾上腺皮质激素水平预测糖尿病肾病患者钙磷代谢紊乱价值分析[J]. 疑难病杂志,2021,20(8):770-774. DOI: 10.3969/j.issn.1671-6450.2021.08.004.
[12] 侯文雁,宋玮,吴敬,等. 金匮肾气丸联合坎地沙坦酯治疗老年糖尿病肾病的疗效及对微炎症状态的影响[J]. 中国老年学杂志,2023,43(16):3936-3939. DOI: 10.3969/j.issn.1005-9202.2023.16.029.
[13] Wong WS, McKay G, Stevens KI. Diabetic kidney disease and transplantation options[J]. Practical Diabetes, 2021, 38(2): 28-33b. DOI:10.1002/pdi.2330.
[14] Sawaf H, Thomas G, Taliercio JJ, et al. Therapeutic advances in diabetic nephropathy [J]. J Clin Med, 2022, 11(2):378. DOI: 10.3390/jcm11020378.
[15] Wang J, Xiang H, Lu Y, et al. New progress in drugs treatment of diabetic kidney disease [J]. Biomed Pharmacother, 2021, 141: 111918. DOI: 10.1016/j.biopha.2021.111918.
[16] 郭燕. 血清Ca、P、iPTH、HbA1c表达水平与糖尿病肾病血透患者预后的相关性[J]. 中外医学研究,2024,22(3):162-165. DOI:10.14033/j.cnki.cfmr.2024.03.042.
[17] Sörensen I, Susnik N, Inhester T, et al. Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis [J]. Kidney Int, 2011, 80(10): 1035-1044. DOI:10.1038/ki.2011.214.
[18] Li S, Zhang X, Lou C, et al. Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma [J]. Front Oncol, 2022, 12: 1003845. DOI: 10.3389/fonc.2022.1003845.
[19] Sulimai N, Lominadze D. Fibrinogen and/or fibrin as a cause of neuroinflammation [J]. Online J Neurol Brain Disord, 2021, 5(4): 217.
[20] Sui J, Noubouossie DF, Gandotra S, et al. Elevated plasma fibrinogen is associated with excessive inflammation and disease severity in COVID-19 patients [J]. Front Cell Infect Microbiol, 2021, 11:734005. DOI: 10.3389/fcimb.2021.734005.
[21] Li R, Li L, Liu B, et al. Associations of levels of peripheral blood leukocyte and subtypes with type 2 diabetes: a longitudinal study of Chinese government employees [J]. Front Endocrinol (Lausanne), 2023, 14: 1094022. DOI: 10.3389/fendo.2023.1094022.
[22] Menart-Houtermans B, Rütter R, Nowotny B, et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS) [J]. Diabetes Care, 2014, 37(8): 2326-2333. DOI: 10.2337/dc14-0316.
[23] Gkrania-Klotsas E, Ye Z, Cooper AJ, et al. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies [J]. PLoS One, 2010, 5(10): e13405. DOI: 10.1371/journal.pone.0013405.
[24] Gkrania-Klotsas E, Ye Z, Cooper AJ, et al. Differential white blood cell count and type 2 diabetes: systematic review and meta-analysis of cross-sectional and prospective studies [J]. PLoS One, 2010, 5(10): e13405. DOI: 10.1371/journal.pone.0013405.
[25] Pérez-Morales RE, Del Pino MD, Valdivielso JM, et al. Inflammation in diabetic kidney disease [J]. Nephron, 2019, 143(1): 12-16. DOI: 10.1159/000493278.
[26] Donate-Correa J, Ferri CM, Sánchez-Quintana F, et al. Inflammatory cytokines in diabetic kidney disease: pathophysiologic and therapeutic implications [J]. Front Med (Lausanne), 2021, 7: 628289. DOI: 10.3389/fmed.2020.628289.
[27] Yu D, Shang J, Cai Y, et al. A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes [J]. Diabet Med, 2020, 37(10): 1728-1736. DOI: 10.1111/dme.14195.
[28] Lu P, Lin D, Chen N, et al. CNN-assisted SERS enables ultra-sensitive and simultaneous detection of Scr and BUN for rapid kidney function assessment [J]. Anal Methods, 2023, 15(3): 322-332. DOI: 10.1039/d2ay01573k.
[29] 于璐,张珂珂,王静,等. 血小板与淋巴细胞比值在老年人2型糖尿病致肾功能损伤患者中的相关性研究[J]. 中华老年医学杂志,2018,37(8):883-887. DOI:10.3760/cma.j.issn.0254-9026.2018.08.011.
|